2-year outcomes of ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW extension study): prospective follow-up of an open label, randomised controlled trial
Authors: Neil Marlow, Andreas Stahl, Domenico Lepore, Alistair Fielder, James D Reynolds, Qi Zhu, Annemarie Weisberger, Daniel P Stiehl, Brian Fleck